INTRODUCTION
To explain historically low rates of participation in cancer clinical trials [1] [2] [3] , several factors have been studied. These include intrinsic patient characteristics, such as age [3] [4] [5] , gender [3] , race [3, 6 -8] , and socioeconomic status [6, 9] . Additionally, physician characteristics, attitudes toward patients [10] , and communication skills [10 -14] have been associated with study accrual rates. However, the role of nonphysician research personnel has not been well studied. Rather than physicians, it is often these individualswho include research nurses and clinical research associates-who carry out the process of consenting and enrolling patients in clinical trials. This process entails explaining the study protocol in detail, educating patients about the role and potential benefits of a clinical trial, and addressing questions and concerns raised by patients, family members, and friends. These represent potentially critical steps in the accrual process, because patient mistrust [15] and poor understanding of study protocols [16] have been associated with a lower likelihood of enrollment in clinical trials.
Studying patient interest in research in the setting of therapeutic clinical trials may be complicated by extrinsic factors. For instance, limited study availability [17] and stringent eligibility criteria [18] may impact accrual, independent of patient interest. By contrast, nontherapeutic translational research may offer a more suitable context to evaluate patient interest and the role of study consenters. These studies generally have relatively broad eligibility criteria. Furthermore, these studies pose relatively little risk to patients and do not affect treatment decisions. Accordingly, considering participation in such research may entail less counseling by the treating physician, thereby relegating a greater role to nonphysician study personnel.
Nontherapeutic translational studies represent a growing area of clinical research. Even though the majority of such studies pose little risk and inconvenience to patients, a meaningful proportion of patients decline to participate [19] . The largely unstudied area of consenter characteristics and experience may offer insight into means of improving accrual to observational research. These factors may, to some extent, also prove relevant to therapeutic clinical trial accrual. Using data from a cancer center tissue repository, we therefore examined the relationship between consenter demographic characteristics and experience and subject willingness to be contacted for medical follow-up information and for future research participation. The latter was considered an indicator of subjects' interest in research.
MATERIALS AND METHODS

Data Source and Research Setting
The University of Texas Southwestern (UTSW) Tissue Resource is a university-based tissue repository. Since its inception in 2000, it has stored tissue and blood samples from consenting patients who are undergoing a biopsy or surgical procedure for suspected or confirmed cancer. Tissue and/or blood samples, along with corresponding clinical data, are collected prospectively and archived for future translational cancer research. The consent form for the UTSW Tissue Resource includes the following two questions: (a) "May members of the University of Texas Southwestern Medical Center Tissue Resource contact you in the future for follow-up information?" and (b) "May members of the University of Texas Southwestern Medical Center Tissue Resource contact you in the future to ask you to take part in more research?" The consent form was written at an eighthgrade reading level, and is available in both English and Spanish. Participation in the Tissue Resource is not dependent on the answers to these questions.
Subjects in the UTSW Tissue Resource are recruited from various public and private clinical facilities affiliated with UTSW. Parkland Health and Hospital System includes a 968-bed public hospital and outpatient clinics that provide care to predominantly indigent residents of Dallas County. Private medical facilities include St. Paul-University Hospital (271 beds), Zale Lipshy-University Hospital (144 beds), and the Harold C. Simmons Comprehensive Cancer Center, a free-standing outpatient facility.
Data Collection
This study was approved by the UTSW Institutional Review Board. For each of the patients enrolled in the UTSW Tissue Resource, we obtained the following data: patient age, gender, race, residence zip code, and the answers to questions (a) and (b) listed above. We also obtained the name of the clinical facility where consent was obtained, as well as the identity of the consenter.
Subject race was characterized as white, African American, Hispanic, or other (which included Middle Eastern, Asian, Native American, African, or unknown). Using subject residence zip code, we obtained median household income according to U.S. Census Tract data, as previously described [20] . Clinical setting was classified as either public or private.
We obtained the age, gender, and race of study consenters from the UTSW Department of Human Resources. In certain instances when consenter demographic information was not available from the human resources department, we were able to obtain consenter gender and race from the Tissue Resource. However, consenter age was not available in these cases. Consenter race was characterized as white, African American, Hispanic, or Asian. Consenter experience was defined according to the number of patients enrolled in the tissue repository. Approximately half of the subjects were enrolled by consenters who had enrolled more than eight subjects. We therefore selected this cutoff value for the analysis.
Statistical Analysis
Subject responses to questions (a) and (b) were analyzed separately. In the univariate analysis, we used the Pearson 2 test to calculate p-values. We obtained odds ratios and 95% confidence intervals (CIs) from the univariate logistic regression. We fitted a multivariate logistic regression model, including the covariates of dichotomized subject age, subject race, subject income, discordance between subject and consenter gender, consenter race, and consenter experience. The quartiles calculated from our dataset were used to categorize the subjects' household income level. All reported p-values are two-sided. All the statistical analyses were implemented by SAS 9.1 for Windows (SAS Institute Inc., Cary, NC).
RESULTS
Consenter Characteristics
From June 2000 to September 2007, 922 subjects were enrolled in the UTSW Tissue Resource. We determined consenter identity for 883 of 922 (96%) subjects, representing a total of 181 consenters. In the remainder of cases, consenter identity was not available because of poor legibility on study forms. Among the 181 consenters, gender, race, and age were available for 90%, 80%, and 22%, respectively. Among the 883 subjects for whom consenter identity was known, consenter gender, race, and age were available for 96%, 92%, and 28%, respectively. The mean consenter age was 40, and 64% were women. The number of subjects enrolled in the Tissue Resource by each consenter ranged from 1 to 95. Most consenters (76%) enrolled one to five patients. However, 53% of patients (for whom consenter identity was known) were enrolled by a consenter who enrolled more than eight patients. Additional consenter characteristics, presented by both consenter (n ϭ 181) and subject (n ϭ 883) cohorts, are presented in Table 1 .
Subject Characteristics
Gender, race, age, and zip code were available for 100%, 98%, 99%, and 96% of subjects, respectively. The mean subject age was 56, 67% were female, and 64% were white. The median household income was U.S. $46,470 (compared with $44,815 for Dallas County, $44,922 for Texas, and $48,451 for the U.S. as a whole). Additional patient characteristics are listed in Table 2 . Results are presented as distributed among the population of consenters (n ϭ 181) and as distributed among the study consents for whom consenter identity was known. Abbreviation: SD, standard deviation.
Estimates from Univariate and Multivariate Analyses
The majority of subjects agreed to be contacted in the future to provide follow-up information (question a) (84.9%; 95% CI, 82.5%-87.2%) and to be asked to participate in other research studies (question b) (83.1%; 95% CI, 80.6%-85.5%). Responses to these questions were highly correlated, with 96% of subjects answering either "yes" to both or "no" to both (two-sided p-value Ͻ .001).
In univariate analysis (Table 3) , consenter experience and subject-consenter gender discordance were associated with subject responses. Greater consenter experience, defined as enrolling more than eight subjects (the median), was associated with a higher rate of patients agreeing to be contacted for future research ("yes" ϭ 85.4%), compared with lesser experience (eight or fewer patients) ("yes" ϭ 80.1%; p ϭ .05). When subject and consenter gender differed (subject-consenter gender discordance), there was a trend toward a higher rate of patients agreeing to be contacted for future research ("yes" ϭ 86.8%), compared with scenarios in which subject and consenter gender were the same ("yes" ϭ 82.0%; p ϭ .09). Older subject age (Ͼ56 years, the mean) was associated with a significantly lower rate of agreeing to be contacted to provide follow-up ("yes" ϭ 81.8%), compared with younger patients (Յ56 years) ("yes" ϭ 88.1%; p ϭ .01). Consenter gender and race were not associated with patient answers, nor were patient age, gender, race, and income. Because the majority of patients and consenters were white, we were not able to analyze the effect of race matching between patient and consenter.
A multivariate analysis (Table 4) yielded similar results. Consenter experience and subject-consenter gender discordance remained associated with subject responses. Older subject age was again associated with a significantly lower rate of agreeing to be contacted to provide follow-up (p ϭ .01) and a trend toward a lower rate of agreeing to be contacted to participate in future research studies (p ϭ .06). Consenter gender and race and subject gender, race, and income were not associated with subject responses.
DISCUSSION
In this study of 922 subjects who provided tissue and/or blood to a university-based tissue repository, the majority of subjects agreed to be contacted in the future to participate in other research studies, a response that we considered as an indicator of subjects' interest in research. Greater consenter experience was associated with higher rates of interest in future research. Unexpectedly, subjects also expressed greater interest in research when subject and consenter gender differed. Importantly, other consenter (gender and race) and subject (gender, age, race, and income) characteristics did not seem to impact subject willingness to be contacted for future clinical research. As has been reported in other studies [3] [4] [5] , older subject age was associated with a trend toward less interest in future research opportunities.
To our knowledge, this is the first study to examine the impact of consenter characteristics and experience on subject interest in clinical research. Because of the size and location (large, urban academic medical center) of the study, the subject population encompassed a diverse range of ages, races, and income levels. The etiology of the study cohort also warrants comment. Participation in the UTSW Tissue Resource entails providing basic clinical information and permitting tissue (obtained for other, clinically indicated purposes) to be designated and stored for translational research purposes. Because no additional procedures are required, the overwhelming majority of cancer patients undergoing surgical or diagnostic procedures at UTSW agree to participate in the Tissue Resource. Unfortunately, we do not have information on patients who either declined to participate or were not offered the opportunity to do so. That stated, given the nature of participation in the Tissue Resource, we believe this cohort is at least as representative a patient sample as those in studies incorporating surveys or questionnaires. Such studies may be prone to selection bias, because response rates are generally low (21%-33%) [21] [22] [23] , and may overrepresent a population generally supportive of and interested in medical research. The design of our study also optimizes the evaluation of consenter-associated factors. The questions regarding contact for medical follow-up and participation in future research are carefully reviewed with patients by study consenters. In contrast, physicians referring patients to the Tissue Resource tend not to discuss the questions with patients, because responses do not impact enrollment. Thus, subject responses are unlikely to be influenced by the referring medical provider and instead reflect patient interaction with study personnel. OR Ͼ1 indicates that the subject is more likely to respond "yes." Abbreviations: CI, confidence interval; OR, odds ratio.
In this cohort, over 80% of patients agreed to be contacted for medical follow-up or for other future research studies. That subject responses regarding follow-up and future research were highly correlated (p Ͻ .001) may indicate that patient concerns regarding confidentiality and perceived inconvenience-likely reasons to decline to provide medical follow-up information-also discourage participation in clinical trials.
This high rate of interest in clinical research opportunities may seem surprising, given the low rate of participation in trials overall, and may suggest that nonpatient factors, such as clinical trial availability and eligibility criteria, may account for much of the difficulty in accruing patients to cancer clinical trials. A recent study found that 43% of patients referred to the National Cancer Institute (NCI) specifically for the possibility of a clinical trial were not actually offered participation in a clinical trial [24] . Lara et al. [17] found that there was no clinical trial available for 53% of patients seen at an NCI-designated cancer center. These reports may in part reflect the trend toward increasingly stringent eligibility criteria, which not only hinders study accrual but also reduces the generalizability of study results [18] .
Consenter experience was associated with a greater likelihood of subjects agreeing to be contacted for medical follow-up and future research. This may reflect greater knowledge of the study protocol and, consequently, better communication skills. Albrecht et al. [25] showed that patients are more likely to enroll in a clinical trial if there is more communication and trust between physician and patient, if the physician is more responsive to patient ques- [11, 13, 14] , quality of informed consent [12] , and patient satisfaction [12] related to cancer clinical trials. These effects may persist for several months after such an intervention [26] .
In multivariate analysis, we found that when consenter and subject gender differed, subjects had a higher rate of agreeing to be contacted for participation in future research studies. This unanticipated result stands in contrast to numerous studies demonstrating that, in general, patients prefer physicians of the same gender [27] [28] [29] . Kerssens et al. [28] found that women preferred female providers for nursing and obstetrical care, although men rarely expressed a preference for physician gender. Women cited ease of communication and comfort with gynecologic examinations as the main reasons for their preference. In a study by Nichols et al. [29] , women preferred female physicians because they were "easier or less embarrassing to talk to," and they were perceived to have a "better understanding of (female) problems." It is possible that this study (in which the majority of subjects and consenters were women) did not find an apparent benefit of having a consenter of the same gender because the process of reviewing a protocol and signing informed consent does not involve the same level of personal information as does a clinical encounter. However, this does not explain why, in this study, discordance between subject and consenter was associated with higher levels of interest in future research, an observation that certainly requires further investigation.
The principal limitation of this study is that only patients who consented to provide tissue and/or blood to the UTSW Tissue Resource were included. However, as discussed above, we believe this design may introduce less selection bias than questionnaire-based studies. Another potential shortcoming is that our measure of consenter experience takes into account only the number of subjects a consenter enrolled in the UTSW Tissue Resource. Some research personnel may have enrolled large numbers of patients into other studies, which could contribute to consenting skills. That we still found an association between consenter experience-using a study-specific definition-and patient responses highlights the importance of study-specific knowledge among research staff. Furthermore, we recognize that some subjects enrolled by an "experienced" consenter were enrolled at a point when that consenter was not yet experienced. Despite this limitation, there was still an association between consenter experience and subject responses in this study. This may suggest that other, related factors-such as consenter interest in and enthusiasm for a study-may play a role in addition to "experience" among high-volume consenters. Separately, the present study does not address why patients declined to be contacted for medical follow-up or research, because this information was not sought during the consent process for the Tissue Resource.
We also acknowledge that there is a clear difference between agreeing to be contacted regarding future researchthe outcome in this study-and actually committing to participate in research. This is particularly true for therapeutic clinical trials, in which decisions may have direct consequences on patient survival and quality of life. Despite this distinction, we believe that our findings have relevance to multiple research settings. Patient interest in clinical research represents a necessary step in study accrual. That approximately 15% of patients in this cohort did not wish to be contacted for future research suggests that this step is indeed a contributing factor to study enrollment. Furthermore, our findings are likely to be highly applicable to translational cancer studies (in which patients are asked to provide medical information and tissue specimens but do not receive experimental treatment), a rapidly growing area of clinical research.
In conclusion, we found that the majority of subjects enrolled in a tissue repository were interested in participating in other research studies. The level of interest was not associated with subject gender, race, or income. Similarly, clinical characteristics of consenters, including gender and race, were not associated with subject willingness to consider future research. However, consenter experience did appear to affect subject interest in research. We were surprised that subjects were also more likely to agree to be contacted for future research when subject and consenter gender differed. To date, interactions between patients and research staff have received relatively little attention in studies of clinical trial participation. This important step in the research process should be considered in future studies and efforts to increase accrual to clinical trials. 
